Sheel Biotech Limited (NSE:SHEEL)

Sheel Biotech Financials Overview

Financials in millions INR. Fiscal year is April - March.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Revenue Revenue Growth	1,100	1,100	1,018	922.82	801.16	707.36
Revenue Growth	-2.05%	8.13%	10.26%	15.19%	13.26%	12.23%
Gross Profit Gross Profit Growth	420.72	420.72	360.37	346.6	259.73	229.09
Operating Income Operating Income Growth	152.18	152.18	141.49	135.49	78.17	55.3
Net Income Net Income Growth	117.56	117.56	106.36	104.75	50.77	48.57
Earnings Per Share EPS Growth	6.69	6.69	7.21	7.22	3.50	3.35
EPS Growth	-32.71%	-7.21%	-0.14%	106.29%	4.51%	-65.58%

Revenue by Geography

Chart

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
India India Growth	1,017	922.82	801.16	707.36
Export Export Growth	0.4	-	-	-
Total Total Growth	1,018	922.82	801.16	707.36

Cash & Debt

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Investments Cash & Investments Growth	21.83	21.83	20.7	18.3	14.7	3.11
Total Debt Total Debt Growth	89.79	89.79	173.61	235.4	191.71	235.83
Net Cash (Debt) Net Cash Growth	-67.96	-67.96	-152.91	-217.1	-177.01	-232.72
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share Net Cash Per Share Growth	-3.87	-3.87	-10.37	-14.97	-12.20	-16.05

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Operating Cash Flow Operating Cash Flow Growth	-175.69	-175.69	92.08	-9.2	92.92	21.91
Capital Expenditures CapEx Growth	-66.6	-66.6	-12.38	-2.94	-11.55	-12.09
Free Cash Flow Free Cash Flow Growth	-242.28	-242.28	79.7	-12.14	81.38	9.81
Free Cash Flow Growth	-	-	-	-	729.34%	-

Margins

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Gross Margin	38.24%	38.24%	35.42%	37.56%	32.42%	32.39%
Operating Margin	13.83%	13.83%	13.91%	14.68%	9.76%	7.82%
Pretax Margin	12.74%	12.74%	12.60%	13.28%	7.95%	6.86%
Profit Margin	10.69%	10.69%	10.45%	11.35%	6.34%	6.87%
FCF Margin	-22.02%	-22.02%	7.83%	-1.31%	10.16%	1.39%

Valuation

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 22, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	8.97	6.93	-	-	-	-
PS Ratio	1.11	0.74	-	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 21, 2026

Data Sources Report a data error